Statin use vs. average non-HDL cholesterol levels in Burkina Faso
Burkina Faso: Statin use vs. average non-HDL cholesterol levels was 2.6 in 2018. ▲ Rising
Statin use vs. average non-HDL cholesterol levels in Burkina Faso, 1980–2018
Source: World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.
Analysis
In 2018, statin use vs. average non-hdl cholesterol levels in Burkina Faso stood at 2.6. That is the highest value across all 39 years on record.
That represents a change of up 4.0% over ten years.
Over the whole period, statin use vs. average non-hdl cholesterol levels in Burkina Faso peaked at 2.6 in 2013 and was at its lowest, 2, in 1980.
That places Burkina Faso 187th out of 191 countries with data for 2018, putting it in the bottom quarter.
The long-run direction has been consistently rising across the 39 years of available data.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1980s | 2.13 | 2 | 2.2 | 10 |
| 1990s | 2.32 | 2.2 | 2.4 | 10 |
| 2000s | 2.46 | 2.4 | 2.5 | 10 |
| 2010s | 2.57 | 2.5 | 2.6 | 9 |
Countries ranked near Burkina Faso
More reference data data for Burkina Faso
- Emission Totals - Indirect emissions (N2O) - Agricultural Soils 9.33 (2050)
- Emission Totals - Indirect emissions (N2O) - Crop Residues 0.4137 (2050)
- Emission Totals - Indirect emissions (N2O) - Manure applied to Soils 0.9232 (2050)
- Emission Totals - Indirect emissions (N2O) - Manure left on Pasture 7.39 (2050)
- Emission Totals - Indirect emissions (N2O) - IPCC Agriculture 9.33 (2050)
- Emission Totals - Direct emissions (N2O) - Manure left on Pasture 26.39 (2050)
- Emission Totals - Emissions (CO2eq) from CH4 (AR5) - Burning - Crop re 65.81 (2050)
- Emission Totals - Emissions (CO2eq) from CH4 (AR5) - Enteric Fermentat 18,150 (2050)
- Emission Totals - Emissions (CO2eq) (AR5) - Crop Residues 596.93 (2050)
- Emission Totals - Emissions (CO2eq) from N2O (AR5) - Burning - Crop re 16.15 (2050)
Frequently asked questions
- What is statin use vs. average non-hdl cholesterol levels in Burkina Faso?
- Statin use vs. average non-hdl cholesterol levels in Burkina Faso was 2.6 in 2018, according to World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.
- What is the highest statin use vs. average non-hdl cholesterol levels recorded in Burkina Faso?
- The highest recorded value was 2.6 in 2013.
- What is the lowest statin use vs. average non-hdl cholesterol levels recorded in Burkina Faso?
- The lowest recorded value was 2 in 1980.
- How does Burkina Faso rank for statin use vs. average non-hdl cholesterol levels?
- Burkina Faso ranks 187th out of 191 countries with data for 2018.
- Is statin use vs. average non-hdl cholesterol levels rising or falling in Burkina Faso?
- Over the last ten years it is up 4.0%. The long-run trend across the full record is rising.
- Where does this Burkina Faso data come from?
- The figures come from World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as part of Statin use vs. average non-HDL cholesterol levels. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 39 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.